Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Sinotau Pharma Completes $152 Million E Round for Radiopharmaceutical Portfolio

publication date: Jul 11, 2023

Guangdong Sinotau Pharmaceuticals raised $152 million in its sixth funding round to support its portfolio of novel diagnostic and therapeutic radiopharmaceuticals for use in cardiovascular, neurodegenerative disease and cancer indications. The company’s first five rounds raised $128 million. Founded in 2005, the company began developing radiopharmaceuticals in 2014, when it entered a US JV to develop a diagnostic product for Alzheimer’s, sourced from Merck. Sinotau continues to hold China rights to the product along with a coronary heart disease diagnostic based on myocardial perfusion. One year ago, Tus-Pharmaceutical acquired Sinotau from Beijing Xiantongyuan Pharma for an undisclosed amount. More details....

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital